PIK3CD and systemic lupus erythematosus: Consistent with a role for PI3K in promoting cell survival, SLE patients exhibit an expanded population of CD4+ memory T cells, as well as defective activation-induced cell death (AICD) of T cells, a defect that can be corrected in vitro by pharmacological inhibition of p110δ with IC87114.